Antibodies to TNF-α:: Too little, too late?

被引：5

作者：

Kirschenbaum, L ^{[1
]}

Astiz, M ^{[1
]}

Rackow, EC ^{[1
]}

机构：

[1] St Vincent Hosp & Med Ctr, New York, NY 10011 USA

来源：

CRITICAL CARE MEDICINE | 1998年 / 26卷 / 10期

关键词：

tumor necrosis factor-alpha; sepsis; cytokines; septic shock;

D O I：

10.1097/00003246-199810000-00004

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1625 / 1626

页数：2

共 11 条

[1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].

ABRAHAM, E ;

WUNDERINK, R ;

SILVERMAN, H ;

PERL, TM ;

NASRAWAY, S ;

LEVY, H ;

BONE, R ;

WENZEL, RP ;

BALK, R ;

ALLRED, R ;

PENNINGTON, JE ;

WHERRY, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941

[2]

Abraham E, 1998, LANCET, V351, P929

[3] REPEATED ADMINISTRATION OF A F(AB')2 FRAGMENT OF AN ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY IN PATIENTS WITH SEVERE SEPSIS - EFFECTS ON THE CARDIOVASCULAR-SYSTEM AND CYTOKINE LEVELS [J].

BOEKSTEGERS, P ;

WEIDENHOFER, S ;

ZELL, R ;

PILZ, G ;

HOLLER, E ;

ERTEL, W ;

KAPSNER, T ;

REDL, H ;

SCHLAG, G ;

KAUL, M ;

KEMPENI, J ;

STENZEL, R ;

WERDAN, K .

SHOCK, 1994, 1 (04) :237-245

[4] Effect of a chimeric antibody to tumor necrosis factor-α on cytokine and physiologic responses in patients with severe sepsis -: A randomized, clinical trial [J].

Clark, MA ;

Plank, LD ;

Connolly, AB ;

Streat, SJ ;

Hill, AA ;

Gupta, R ;

Monk, DN ;

Shenkin, A ;

Hill, GL .

CRITICAL CARE MEDICINE, 1998, 26 (10) :1650-1659

[5] CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK [J].

DHAINAUT, JFA ;

VINCENT, JL ;

RICHARD, C ;

LEJEUNE, P ;

MARTIN, C ;

FIEROBE, L ;

STEPHENS, S ;

NEY, UM ;

SOPWITH, M ;

MERCAT, A ;

EDOUARD, A ;

FRIEDMAN, G ;

MARIN, N ;

SCHLEMMER, B ;

LEPAPE, A ;

NOVAK, C .

CRITICAL CARE MEDICINE, 1995, 23 (09) :1461-1469

[6] Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha [J].

Fekade, D ;

Knox, K ;

Hussein, K ;

Melka, A ;

Lalloo, DG ;

Coxon, RE ;

Warrell, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (05) :311-315

[7] INFLUENCE OF AN ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODY ON CYTOKINE LEVELS IN PATIENTS WITH SEPSIS [J].

FISHER, CJ ;

OPAL, SM ;

DHAINAUT, JF ;

STEPHENS, S ;

ZIMMERMAN, JL ;

NIGHTINGALE, P ;

HARRIS, SJ ;

SCHEIN, RMH ;

PANACEK, EA ;

VINCENT, JL ;

FOULKE, GE ;

WARREN, EL ;

GARRARD, C ;

PARK, G ;

BODMER, MW ;

COHEN, J ;

VANDERLINDEN, C ;

CROSS, AS ;

SADOFF, JC ;

GORECKI, J ;

DUBIN, HG ;

GARNER, C ;

KAYE, W ;

LANORE, JJ ;

MIRA, JP ;

ZIMMERMAN, J ;

DELLINGER, RP ;

TAYLOR, RW ;

DAHL, S ;

SHELLY, M ;

MORTIMER, A ;

EDWARDS, JD ;

KETT, DH ;

QUARTIN, A ;

PENA, MA ;

BAKKER, J ;

ALBERSON, TE ;

WALBY, W ;

RADCLIFFE, J ;

YOUNG, D ;

MCQUILLAM, P ;

BELLINGHAM, G ;

BURMAN, W ;

SADOFF, JS ;

YOUNG, L .

CRITICAL CARE MEDICINE, 1993, 21 (03) :318-327

[8] NATURAL CYTOKINE ANTAGONISTS AND ENDOGENOUS ANTIENDOTOXIN CORE ANTIBODIES IN SEPSIS SYNDROME [J].

GOLDIE, AS ;

FEARON, KCH ;

ROSS, JA ;

BARCLAY, GR ;

JACKSON, RE ;

GRANT, IS ;

RAMSAY, G ;

BLYTH, AS ;

HOWIE, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (02) :172-177

[9] MODULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) RELEASE IN THE COURSE OF PRETRANSPLANT CONDITIONING - ROLE OF CONDITIONING REGIMENS AND PROPHYLACTIC APPLICATION OF A MONOCLONAL-ANTIBODY NEUTRALIZING HUMAN TNF-ALPHA (MAK 195F) [J].

HOLLER, E ;

KOLB, HJ ;

MITTERMULLER, J ;

KAUL, M ;

LEDDEROSE, G ;

DUELL, T ;

SEEBER, B ;

SCHLEUNING, M ;

HINTERMEIERKNABE, R ;

ERTL, B ;

KEMPENI, J ;

WILMANNS, W .

BLOOD, 1995, 86 (03) :890-899

[10] Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study [J].

Reinhart, K ;

WiegandLohnert, C ;

Grimminger, F ;

Kaul, M ;

Withington, S ;

Treacher, D ;

Eckart, J ;

Willatts, S ;

Bouza, C ;

Krausch, D ;

Stockenhuber, F ;

Eiselstein, J ;

Daum, L ;

Kempeni, J .

CRITICAL CARE MEDICINE, 1996, 24 (05) :733-742

← 1 2 →